Zions Bancorporation, National Association’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$716K Sell
51,959
-33,027
-39% -$498K 0.05% 216
2025
Q4
$1.53M Buy
84,986
+22,351
+36% +$401K 0.07% 184
2025
Q3
$1.16M Buy
+62,635
New +$984K 0.06% 212

Other funds holding CLBT

Zions Bancorporation, National Association's CLBT Position: Q1 2026 in Review

Zions Bancorporation, National Association reduced its Cellebrite (CLBT) stake by 39% in Q1 2026, selling an estimated $498K and leaving 51,959 shares worth $716K. The position accounts for 0.05% of the portfolio, ranked #216.

Zions Bancorporation, National Association first reported a position in CLBT in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.53M in Q4 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Zions Bancorporation, National Association held 51,959 shares of Cellebrite worth $716K as of Q1 2026.
  • Zions Bancorporation, National Association sold 33,027 Cellebrite shares in Q1 2026, an estimated $498K.
  • Cellebrite made up 0.05% of Zions Bancorporation, National Association's portfolio in Q1 2026, its #216 holding.
  • Zions Bancorporation, National Association first reported a position in Cellebrite in Q3 2025 and has held it in 3 quarters since.
  • Zions Bancorporation, National Association's Cellebrite position peaked at $1.53M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q1 2026, filed 8 May 2026.